Vol 4, No 6 (December 28, 2015): Translational Lung Cancer Research (Lung Cancer Immunotherapy)

Preface on Lung Cancer Immunotherapy1

Immunotherapy for lung cancer
María González-Cao

Review Article on Lung Cancer Immunotherapy2

Lung cancer in HIV-infected patients in the combination antiretroviral treatment era
José Moltó, Teresa Moran, Guillem Sirera, Bonaventura Clotet
Cancer stem cells and immunoresistance: clinical implications and solutions
Jordi Codony-Servat, Rafael Rosell
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer
Sara Pilotto, Luisa Carbognin, Niki Karachaliou, Marina Garassino, Federica Cuppone, Sandra Petraglia, Rafael Rosell, Giampaolo Tortora, Emilio Bria
Platelets and their role in cancer evolution and immune system
Niki Karachaliou, Sara Pilotto, Emilio Bria, Rafael Rosell
Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity
Sara Pilotto, Miguel Angel Molina-Vila, Niki Karachaliou, Luisa Carbognin, Santiago Viteri, Maria González-Cao, Emilio Bria, Giampaolo Tortora, Rafael Rosell
Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role
Mariacarmela Santarpia, María González-Cao, Santiago Viteri, Niki Karachaliou, Giuseppe Altavilla, Rafael Rosell
Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis
Nitin Chakravarti, Victor G. Prieto
Immunotherapy meets targeted therapy: will this team end the war against cancer?
Daniela Morales-Espinosa, Silvia García-Román, Cristina Teixidó, Niki Karachaliou, Rafael Rosell
Results of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancer
Santiago Viteri, María González-Cao, Feliciano Barrón, Aldo Riso, Rafael Rosell

Original Article

The incidence and mortality of lung cancer and their relationship to development in Asia
Reza Pakzad, Abdollah Mohammadian-Hafshejani, Mahshid Ghoncheh, Iraj Pakzad, Hamid Salehiniya
Crocin inhibits cell proliferation and enhances cisplatin and pemetrexed chemosensitivity in lung cancer cells
Shuangshuang Chen, Shuang Zhao, Xinxing Wang, Luo Zhang, Enze Jiang, Yuan Gu, Anna Junjie Shangguan, Hong Zhao, Tangfeng Lv, Zhenghong Yu
Lung cancer treatment outcomes in recipients of lung transplant
Lingling Du, Nathan A. Pennell, Paul Elson, Nooshin Hashemi-Sadraei

Disclosure:

1. The series “Lung Cancer Immunotherapy” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. María González-Cao served as the unpaid Guest Editor for the series.

2. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.

3. The series “Meet the Professor” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.